Glycoprotein IIb/IIIa inhibitors
Lincoff, A.M.
Journal of Invasive Cardiology 16(7 Suppl): 11s-16s
2004
ISSN/ISBN: 1042-3931 PMID: 23573566 Document Number: 570732
The role of glycoprotein (GP) IIb/IIIa inhibitors in interventional cardiology continues to evolve. This review focuses on contemporary research to evaluate the appropriate context for the use of GP IIb/IIIa inhibitors.
Document emailed within 1 workday
Related Documents
Subbarao, V.D.; Phillips, J.; Stouffer, G.A. 1999: Use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease American Journal of the Medical Sciences 318(2): 107-114Quinn, M.J.; Moliterno, D.J. 2002: Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes Minerva Cardioangiologica 50(5): 547-553
Ottani, F.; Bresciani, B.; La Vecchia, L.; Favero, L.; Fontanelli, A.; Galvani, M. 2002: Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 3(5): 544-554
Hostetter, J.C.; Bhatt, D.L. 2003: The expanding role of antiplatelet agents in coronary artery disease. a current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines Minerva Cardioangiologica 51(5): 531-546
Mishkel, G.J.; Moore, A.L.; Markwell, S.J.; Ligon, R.W. 2007: Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results Journal of Invasive Cardiology 19(2): 63-68
Kitagawa, H.; Yamamoto, N.; Yamamoto, K.; Tanoue, K.; Kosaki, G.; Yamazaki, H. 1989: Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells Cancer Research 49(3): 537-541
Hermanides, R.S.; Ottervanger, J.P.; ten Berg, J.M.; Gosselink, A.T.M.; van Houwelingen, G.; Dambrink, J.-H.E.; Stella, P.R.; Hamm, C.; van 't Hof, A.W.J. 2012: Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score Journal of Invasive Cardiology 24(3): 84-89
Kessler, S.; Kessler, D.; Frishman, W.H. 1999: Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists Drugs of Today 35(6): 413-418
Singh, S.; Gopal, A.K.; Bahl, V.K. 2005: Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence Indian Heart Journal 57(3): 201-209
Kondo, K. 2000: Investigational new drugs among glycoprotein IIb/IIIa-receptor antagonists Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 116(5): 263-268
Rasmussen, L.H.; Husted, S.E.; Clemmensen, P.M.; Gøtzsche, C.O.; Helqvist, S.; Kristensen, S.D.; Pedersen, K.E.; Rasmussen, K.; Rasmussen, S. 2000: Clinical studies on glycoprotein IIb/IIIa receptor antagonist Ugeskrift for Laeger 162(44): 5944-5947
López Cuéllar, J. 1999: Glycoprotein IIb/IIIa blockers. their usefulness in current cardiovascular therapeutics Archivos del Instituto de Cardiologia de Mexico 69(3): 272-281
Cervinka, P. 1998: Clinical use of glycoprotein IIb/IIIa receptor blockers in invasive cardiology Vnitrni Lekarstvi 44(7): 439-443
Gambhir, D.S.; Mukhopadhyay, S. 2000: Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions Indian Heart Journal 52(5): 524-532
Fujimoto, T.; Fujimura, K.; Kuramoto, A. 1990: Role of membrane glycoprotein (GP) IIb-IIIa complex on platelet Ca2+ ion influx Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 86: 34-43
Nichols, A.J.; Vasko, J.A.; Koster, P.F.; Valocik, R.E.; Rhodes, G.R.; Miller-Stein, C.; Boppana, V.; Samanen, J.M. 1994: The in vivo pharmacological profile of the novel glycoprotein IIb/IIIa antagonist, SK&F 106760 Journal of Pharmacology and Experimental Therapeutics 270(2): 614-621
Perutelli, P.; Marchese, P.; Mori, P.G. 1992: The glycoprotein IIb/IIIa complex of the platelets. An activation-dependent integrin Recenti Progressi in Medicina 83(2): 100-104
Heras, M.; Escolar, G. 2000: Eptifibatide: a cyclic peptide that selectively inhibits platelet glycoprotein IIb/IIIa Drugs of Today 36(5): 295-311
Byzova, T.V.; Vlasik, T.N.; Mazurov, A.V. 1994: Inhibition of platelet aggregation with monoclonal antibodies to the glycoprotein IIb-IIIa complex Biulleten' Eksperimental'noi Biologii i Meditsiny 118(10): 402-405
Adelman, A.G.; Caramori, P.R.; Cohen, E.A.; Chisholm, R.J.; Côté, G.; Ducas, J.; O'Neill, B.J.; Tcheng, J.E. 1998: The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent era Canadian Journal of Cardiology 14(8): 1057-1066